BGI Group Signs MOUs in Indonesia to Support Genomics Development

SHENZHEN, China, Nov. 21, 2022 /PRNewswire/ — BGI Group signed three Memorandum of Understandings (MOUs) in the lead up to the G20 Summit in Bali with the Indonesian Ministry of Health, the University of Indonesia and the Del Institute of Technology (Institut Teknologi Del). The MOUs cover genomics development initiatives, construction of related laboratories, and joint research and personnel training.

The signings were witnessed by Coordinating Minister of Maritime and Investment Affairs of Indonesia, Luhut Binsar Pandjaitan, Indonesian Minister of Health, Budi Gunadi Sadikin, and Chairman and Co-Founder of BGI Group, Wang Jian.

Wang Jian also spoke during the “Tri Hita Karana (THK) Future Knowledge Summit” in Bali, an official side event of the G20 Summit, where he delivered a speech on the development of cutting-edge technologies such as single-cell sequencing and spatiotemporal omics, and their impact on precision medicine, public health, and next-generation agricultural tools.

Genomics was announced as an integral part of the Indonesian Ministry of Health’s medical transformation strategy. On August 14th 2022, Indonesia established its first national integrated biomedical programme, the “Biomedical and Genome Science Initiative” (BGSi). MGI Tech Co., Ltd., an independent subsidiary of BGI Group is one of the designated sequencing platform partners for the initiative.

BGI Group, a pioneer in life sciences, is one of the world’s leading biotechnology organizations with operations covering research, production, and applications in more than 100 countries and regions. BGI Group’s work includes ground-breaking science discoveries, innovative research into microbiology and biodiversity, diagnostic testing services to trace viruses and diseases, the development of next generation technologies for large-scale gene sequencing, and the novel spatialomics technology Stereo-seq. BGI placed 1st in Asia Pacific and 8th globally amongst corporates for high-quality scientific research papers in life sciences in the 2022 Nature Index.

Subscribe on LinkedIn

Get the free newsletter

Subscribe to MedicaEx for top news, trends & analysis

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

PR Newswire is solely responsible for the content of the above news submissions. If there are any violations of laws, violations of the membership terms of this website, or the risk of infringing on the rights of third parties, PR Newswire will be solely responsible for legal and damage compensation. Responsibility has nothing to do with MedicaEx.

Generated by Feedzy
TradeWinds at MEDICA Germany

Dusseldorf, Germany 13-16 November 2023

Are you in?

Subscribe to receive exclusive content and notifications to your inbox

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.